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Figure 1 
 
 
Figure 1 Age- and sex-adjusted prevalence of depression with psychotic experiences in 47 countries 
All age- and sex-adjusted estimates were calculated using the United Nations population pyramids for the year 2010. 
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Figure 2 
 
 
 
Figure 2 Associations between physical health conditions and comorbid depression and psychotic experiences (vs. depression 
alone) estimated by multivariable logistic regression 
Abbreviation: OR odds ratio; CI confidence interval 
Models are adjusted for age, sex, setting, marital status, education, wealth, anxiety, and country. 
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Abstract 
Background: The coexistence of depression and psychotic experiences (PEs) is associated 
with more pronounced adverse health outcomes compared to depression alone. However, 
data on its prevalence and correlates are lacking in the general adult population, and there is 
no published data on its association with chronic physical conditions.  
Methods: Cross-sectional, community-based data from 201,337 adults aged ≥18 years from 
47 low- and middle-income countries from the World Health Survey were analyzed. The 
presence of past-12 month PE and DSM-IV depression was assessed with the Composite 
International Diagnostic Interview (CIDI). Information on six chronic medical conditions 
(chronic back pain, edentulism, arthritis, angina, asthma, diabetes) were obtained by self-
report. Multivariable logistic regression analysis was performed. 
Results: The crude overall prevalence of comorbid depression/PE was 2.5% (95%CI=2.3%-
2.7%), with the age- and sex-adjusted prevalence ranging from 0.1% (Sri Lanka, Vietnam) to 
9.03% (Brazil). Younger age, urban setting, current smoking, alcohol consumption, and 
anxiety were significant correlates of co-existing depression/PE. Co-occurring depression/PE 
was associated with significantly higher odds for arthritis, angina, and diabetes beyond that of 
depression alone after adjusting for sociodemographics, anxiety, and country, with ORs 
(depression/PE vs. depression only) being: arthritis 1.30 (95%CI=1.07-1.59; p=0.0086); 
angina 1.40 (95%CI=1.18-1.67; p=0.0002); diabetes 1.65 (95%CI=1.21-2.26; p=0.0017).  
Conclusions: The prevalence of co-existing depression/PE was non-negligible in most 
countries. Our study suggests that when depression/PE or a chronic condition (e.g., arthritis, 
angina, diabetes) is detected, screening for the other may be important to improve clinical 
outcomes. 
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Introduction 
Depression is a pervasive and prevalent mental disorder, affecting approximately 350 
million people, with major depressive disorder accounting for 8.2% of the total worldwide 
years lived with disability (YLDs) (Ferrari et al. 2013). Researchers have extensively 
explored the prevalence, correlates, and clinical outcomes of depression and its subtypes, but 
have conducted far less research on depression with psychotic experiences in the general 
population. Psychotic experiences are attenuated forms of psychotic symptoms which do not 
reach the clinical threshold for a psychosis diagnosis. This condition is common in the 
general population (prevalence 7.2% according to a systematic review) (Linscott & van Os, 
2013), and may present an underlying susceptibility for psychotic disorders such as 
schizophrenia (Werbeloff et al. 2012). Depression and psychotic experiences may co-occur 
due to shared genetic factors (Varghese et al. 2011a), underlying social factors such as 
childhood adversities (Varghese et al. 2011b), or impaired cognitive, social and emotional 
functioning (Weiser et al. 2005). Furthermore, depression and psychotic experiences may 
mutually influence each other leading to the maintenance and/or exacerbation of both 
conditions. For example, depression may increase the likelihood of having a more negative 
appraisal of psychotic experiences, which in turn may further aggravate depression or 
increase levels of stress and anxiety (Yung et al. 2007). This may lead to biological 
alterations resulting in exacerbation and persistence of psychotic experiences (Yung et al. 
2007).  
Recent studies have shown that comorbid depression and psychotic experiences in the 
general population is associated with a myriad of adverse health outcomes when compared to 
depression alone. Specifically, among adolescents and young adults in Munich, Germany, 
depression (and anxiety) with psychotic experiences was associated with higher odds for 
poorer course of mental illness and substance use as well as greater health service use, when 
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compared to anxiety/depression without psychotic experiences (Wigman et al. 2012). 
Furthermore, our previous community-based study using data on adults aged ≥18 years from 
44 low- and middle-income countries (LMICs) showed that comorbid depression and 
psychotic experiences is related to significant declines in health status in the domains of 
cognition, interpersonal activities, and sleep/energy, compared to depression alone (Koyanagi 
et al. 2016a).  
An abundance of literature has demonstrated that both depression (Thase, 2016) and 
psychotic experiences (Moreno et al. 2013; Oh & DeVylder, 2015; Saha et al. 2011a) are 
associated with considerable chronic physical health burden. The interest in chronic physical 
health conditions is critical, as these may be the leading contributors to the premature 
mortality in individuals with depression (Walker et al. 2015) and psychotic experiences 
(Sharifi et al. 2015). However, surprisingly, a paucity of literature has considered the chronic 
physical health comorbidity among people with co-existing depression and psychotic 
experiences. Although one large multi-country study examined the association between 
psychotic experiences and chronic physical conditions, it only adjusted for age, sex, country-
income level, and country, and did not take other non-psychotic mental disorders into account 
(Moreno et al. 2013). Furthermore, while single-country studies from Western settings on 
psychotic experiences and physical health conditions did adjust for non-psychotic mental 
disorders, estimates of risks specific to individuals with comorbid depression and psychotic 
experiences were not provided (Oh & DeVylder, 2015; Saha et al. 2011a).  
Given the scarcity of studies on the risk for adverse health outcomes of comorbid 
depression and psychotic experiences (especially physical health conditions), the lack of data 
on the prevalence and correlates of co-existing depression and psychotic experiences at the 
national level, and the large disease burden attributable to mental disorders as well as the 
rapid increase in non-communicable diseases in LMICs (Beaglehole et al. 2011; Murray et al. 
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2012), the aims of the current study were: (a) to assess the prevalence and correlates of 
comorbid depression and psychotic experiences among adults aged ≥18 year in 47 LMICs 
using predominantly nationally-representative data from more than 200,000 individuals; and 
(b) to examine its association with chronic physical conditions (chronic back pain, edentulism, 
arthritis, angina, asthma, diabetes).  
 
Methods 
The survey 
The World Health Survey (WHS) was a cross-sectional survey carried out in 70 countries in 
2002-2004 with the aim of strengthening national capacity to monitor health outcomes. 
Survey details are available elsewhere (http://www.who.int/healthinfo/survey/en/). Briefly, 
single-stage random sampling and stratified multi-stage random cluster sampling was 
conducted in 10 and 60 countries respectively. Eligible participants were those with a valid 
home address and aged ≥18 years. One individual was randomly chosen from the household 
with the use of Kish tables. The questionnaire was subject to standard translation procedures 
to ensure comparability between countries. Face-to-face interviews and telephone interviews 
were conducted by trained interviewers. The individual response rate (ratio of completed 
interviews among selected respondents after excluding ineligible respondents from the 
denominator) ranged from 63% (Israel) to 99% (Philippines) (Moussavi et al. 2007), with the 
overall individual response rate being 98.5% (Nuevo et al. 2012). To adjust for non-response, 
sampling weights were generated using the population distribution as reported by the United 
Nations Statistical Division. Ethical approval for the survey was provided by ethical boards at 
each study site. All participants gave their informed consent. 
 
Variables 
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Chronic medical conditions 
A total of six chronic medical conditions were assessed. The diagnosis of arthritis, asthma, 
and diabetes was based solely on self-reported lifetime diagnosis. Those who had either or 
both a self-reported diagnosis of angina or a symptom-based angina diagnosis based on the 
Rose questionnaire (Rose, 1962) were considered to have angina. Chronic back pain referred 
to a back pain (including disc problems) occurring everyday during the last 30 days. Those 
who had lost all their natural teeth based on self-report were considered to have edentulism.  
 
Depression 
Past 12-month depression was based on the presence, duration, and persistence of depressive 
symptoms. Algorithms based on the DSM-IV (American Psychiatric Association, 1994) used 
in previous WHS publications were employed (Cifuentes et al. 2008; Loerbroks et al. 2012). 
Respondents were first asked if they experienced any of the following five depressive 
symptoms over the past 12 months: (a) A period lasting several days when you felt sad, 
empty or depressed? (b) A period lasting several days when you lost interest in most things 
you usually enjoy such as hobbies, personal relationships or work? (c) A period lasting 
several days when you have been feeling your energy level decreased or that you were tired 
all the time? (d) Did you lose your appetite? (e) Did you notice any slowing down in your 
thinking?’ Those who answered ‘Yes’ to at least four of the questions were considered to 
have possible depression. Among those with possible depression, individuals who further 
responded ‘Yes’ to both of the following questions were classified as having depression: (a) 
Was this period for more than 2 weeks? (b) Was this period most of the day, nearly every 
day?  
 
Psychotic experiences 
 10 
Positive psychotic symptoms were measured using items from the CIDI 3.0 (Kessler & Ustun, 
2004). This psychosis module has been validated with clinician ratings (Cooper et al. 1998). 
The hallucinations question excluded experiences that took place in the context of sleep or 
substance use. Specifically, respondents could respond ‘yes’ or ‘no’ to the following 
questions:  
During the last 12 months, have you experienced: 
(a) ‘A feeling something strange and unexplainable was going on that other people would 
find hard to believe?’ (delusional mood) 
(b) ‘A feeling that people were too interested in you or there was a plot to harm you?’ 
(delusions of reference and persecution) 
(c) ‘A feeling that your thoughts were being directly interfered or controlled by another 
person, or your mind was being taken over by strange forces?’ (delusions of control) 
(d) ‘An experience of seeing visions or hearing voices that others could not see or hear when 
you were not half asleep, dreaming or under the influence of alcohol or drugs?’ 
(hallucinations) 
Individuals who endorsed at least one of the four aforementioned psychotic symptoms were 
considered to have psychotic experiences. 
 
Smoking and alcohol consumption 
Smoking was assessed using the question: ‘Do you currently smoke any tobacco products 
such as cigarettes, cigars, or pipes?’ with the answer options being ‘daily’, ‘yes, but not daily’, 
or ‘no, not at all’. This variable was dichotomized into those who smoked regardless of 
frequency (i.e., daily or not daily) (current smokers) and those who do not smoke. Alcohol 
consumption was assessed by first asking the question ‘Have you ever consumed a drink that 
contains alcohol (such as beer, wine, etc)?’ Respondents who replied ‘no’ were considered 
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lifetime abstainers. Respondents who replied affirmatively were asked how many standard 
drinks of any alcoholic beverage they had on each day of the past seven days. Females who 
reported consuming at least four drinks, and males who reported consuming at least five 
drinks, on one or two days in the past seven days were considered infrequent heavy drinkers, 
and respondents who drank these amounts at least three days in the past seven days were 
considered frequent heavy drinkers. All other respondents, apart from lifetime abstainers, 
were considered non-heavy drinkers (Hosseinpoor et al. 2012; World Health Organization, 
2002). 
 
Anxiety 
The question ‘Overall in the past 30 days, how much of a problem did you have with worry 
or anxiety’ was used to assess anxiety. The answer options were none, mild, moderate, severe, 
and extreme. In accordance with previous WHS publications, those who answered severe and 
extreme were considered to have anxiety (Koyanagi et al. 2016a; Wong et al. 2013). 
 
Sociodemographic variables 
Information on age, sex, setting (rural or urban), marital status (married/cohabiting, never 
married, separated/divorced/widowed), education (no formal education, primary education, 
secondary or high school completed, or tertiary education completed), and wealth were 
assessed. Principal component analysis based on 15-20 assets was conducted to establish 
country-wise wealth quintiles.  
 
Statistical analysis 
Publically available data of the WHS included 69 countries. The data were nationally-
representative for all countries with the exception of China, Comoros, the Republic of Congo, 
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Ivory Coast, India, and Russia. We excluded 10 countries (Austria, Belgium, Denmark, 
Germany, Greece, Guatemala, Italy, Netherlands, Slovenia, UK) as they lacked sampling 
information. A further nine countries (Finland, France, Ireland, Israel, Luxembourg, Norway, 
Portugal, Sweden, Turkey) were deleted as no information on psychotic symptoms was 
available. Moreover, the remaining two high-income countries (Spain and United Arab 
Emirates) were also deleted, as the focus of this study was on LMICs, while Morocco was 
also omitted due to lack of information on anxiety. Thus, a total of 47 countries, of which 21 
and 26 were low-income and middle-income countries respectively at the time of the survey 
(2003) according to the World Bank, were included in the final sample.  
 The statistical analysis was performed with Stata 14.1 (Stata Corp LP, College station, 
Texas). For all analyses, individuals with a self-reported lifetime diagnosis of psychotic 
disorder such as schizophrenia (n=2395) were omitted so that the estimates obtained are not 
confounded by psychotic disorders (Koyanagi et al. 2016a; Wigman et al. 2012). We 
calculated the country-wise age- and sex-adjusted prevalence of depression with at least one 
psychotic symptom (delusional mood, delusions of reference and persecution, delusions of 
control, or hallucinations) among 201,337 individuals for whom data was available. The 
United Nations population pyramid for the year 2010 was used to calculate the age- and sex-
adjusted estimates. In line with previous publications on comorbid depression and psychotic 
experiences (Koyanagi et al. 2016a; Wigman et al. 2012), we further characterized the study 
sample by a three category variable: (a) no depression and no psychotic experiences (control) 
(n=170,237); (b) depression without psychotic experiences (n=6991); and (c) depression with 
psychotic experiences (n=4313). Individuals with psychotic experiences only (n= 19,796) 
were omitted from this analysis to specifically focus on the significance of psychotic 
experiences in the context of depression. Chi-squared tests and oneway ANOVA (or 
student’s t-tests) were used to test the difference in sample characteristics for categorical and 
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continuous (age) variables respectively. In order to assess the association between depression 
alone or depression with psychotic experiences (exposure variable), and the six chronic 
conditions (outcome variables), we conducted multivariable logistic regression analysis while 
adjusting for age (continuous variable), sex, setting, marital status, education, wealth, anxiety, 
and country. Adjustment for country was done by including dummy variables in the models, 
as in previous WHS publications (Moreno et al. 2013; Nuevo et al. 2012). We did not adjust 
for smoking and alcohol consumption for this analysis as they may be mediators in the 
association between depression/psychotic experiences and physical health conditions. The 
sample weighting and the complex study design were taken into account in all analyses. 
Results from the logistic regression models are presented as odds ratios (ORs) with 95% 
confidence intervals (CIs). The level of statistical significance was set at P<0.05.  
 
Results 
The mean age of the overall sample (i.e., including individuals with psychotic experiences 
alone) was 38.3 (16.0) years with 50.8% being female, while the crude past 12-month 
prevalence (95%CI) of psychotic experiences, depression, and comorbid 
depression/psychotic experiences were 13.7% (13.2%-14.2%), 6.4% (6.1%-6.7%), and 2.5% 
(2.3%-2.7%) respectively. The age- and sex- adjusted past 12-month prevalence of 
depression with psychotic experiences ranged from 0.1% (Sri Lanka, Vietnam) to 9.03% 
(Brazil) with prevalence of >4% also being observed in Nepal (6.76%), Congo (4.64%), India 
(4.54%), and Burkina Faso (4.12%) (Table 1, Figure 1). The sample characteristics by 
different combinations of depression and psychotic experiences are illustrated in Table 2. 
Compared with those with depression alone, individuals with depression and psychotic 
experiences were significantly more likely to be younger, urban residents, have primary 
education (vs. no formal), engage in current smoking and alcohol consumption, and suffer 
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from anxiety, chronic back pain, edentulism, angina, and diabetes, as well as a higher number 
of physical health conditions. The association between depression/psychotic experiences 
groups and physical health conditions estimated by multivariable logistic regression is shown 
in Table 3. Compared to those with no depression or psychotic experiences, significantly 
elevated odds for all chronic physical conditions were observed for depression alone 
[edentulism (OR 1.43; 95%CI=1.09-1.89) to angina (OR 2.46; 95%CI=2.19-2.77)] and 
comorbid depression/psychotic experiences [edentulism (OR 1.39; 95%CI=1.11-1.76) to 
angina (OR 3.45; 95%CI=2.97-4.02)]. The OR was higher for comorbid depression/psychotic 
experiences compared to depression alone for chronic back pain, arthritis, angina, and 
diabetes. In order to assess whether this difference is statistically significant, we also 
conducted the same analysis but changing the reference category to depression alone. The 
ORs (comorbid depression/psychotic experiences vs. depression only) obtained were: chronic 
back pain 1.22 (95%CI=0.97-1.52; p=0.0830); edentulism 0.97 (95%CI=0.69-1.38; 
p=0.8781); arthritis 1.30 (95%CI=1.07-1.59; p=0.0086); angina 1.40 (95%CI=1.18-1.67; 
p=0.0002); asthma 0.94 (95%CI=0.73-1.20; p=0.6131); and diabetes 1.65 (95%CI=1.21-2.26; 
p=0.0017) (Figure 2). 
 
Discussion 
Main findings 
Our study showed that the overall crude prevalence of past-12 month comorbid 
depression/psychotic experiences in 47 LMICs is notable (2.5%) with the highest age- and 
sex-adjusted prevalence being observed in Brazil (9.0%), Nepal (6.8%), Congo (4.6%), India 
(4.5%), and Burkina Faso (4.1%). Compared to those with depression alone, younger age, 
urban residency, current smoking, alcohol consumption, and anxiety were more common in 
comorbid depression/psychotic experiences. Although depression, regardless of the presence 
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of psychotic experiences, was associated with higher odds for all chronic physical conditions, 
the odds were significantly higher for comorbid depression/psychotic experiences than 
depression alone for arthritis, angina, and diabetes. Our results reinforce the notion that 
comorbid depression/psychotic experiences is associated with adverse health outcomes.  
 
Prevalence of co-existing depression/psychotic experiences 
In our study, the overall prevalence of co-existing depression/psychotic experiences in the 
past 12 months was 2.5%. The lowest rates were observed in mostly Asian countries [e.g., Sri 
Lanka (0.10%), Vietnam (0.10%), Myanmar (0.18%), China (0.29%), Kazakhstan (0.45%), 
Laos (0.45%), Georgia (0.50%)], while the highest rates were observed in Brazil (9.03%), 
Nepal (6.76%), Congo (4.64%), India (4.54%), and Burkina Faso (4.12%). While there are no 
previous studies which are totally comparable, the prevalence of depression with psychotic 
“features” was reported to be between 0.2%-0.6% in the general adult population in Western 
settings (Johnson et al. 1991; Ohayon & Schatzberg, 2002). However, since psychotic 
“features” refer to DSM diagnosable symptoms, in contrast to psychotic symptoms which 
include the broader continuum of self-reported psychosis-like phenomena, the lower overall 
prevalence observed in these studies is probably a reflection of the greater psychotic 
symptom severity.  
 
Correlates of comorbid depression/psychotic experiences  
In our study, younger age, urban residency, education, anxiety, smoking, and alcohol 
consumption were significantly associated with comorbid depression/psychotic experiences 
compared to depression alone with no significant differences for sex, marital status, and 
wealth. Some of these findings concur with previous community-based studies of similar 
nature but not all. For example, among adolescents and young adults in Germany, younger 
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age and male sex were associated with comorbid depression/psychotic experiences while 
urbanicity was not (Wigman et al. 2012). Furthermore, depression with psychotic “features” 
was associated with female sex, younger age, and marital status (separated/divorced) in the 
European adult population (Ohayon & Schatzberg, 2002), while in the adult population in the 
US, depression with psychotic “features” was related with female sex, lower socioeconomic 
status, and comorbid mental health conditions (obsessive-compulsive disorder, somatization 
disorder, simple phobia) with no significant differences for marital status, age, and alcohol or 
drug abuse and dependence (Johnson et al. 1991). These varying findings between studies 
may have been due to differences in settings, age groups, and severity of psychotic symptoms. 
The finding that urbanicity was associated with comorbid depression/psychotic experiences 
in adults is novel, and may reflect the increased risk for schizophrenia onset reported to be 
associated with urban upbringing (Padhy et al. 2014) and affective disturbance with 
psychotic experiences (Krabbendam et al. 2005). 
 
Association of comorbid depression/psychotic experiences with chronic physical conditions 
In our study, co-occurring depression/psychotic experiences was associated with significantly 
higher odds for arthritis, angina, and diabetes beyond that of depression alone. The reason 
why only these three conditions were more likely to be associated with comorbid 
depression/psychotic experiences than others is unknown but particularly for angina and 
diabetes, this may be related to unhealthy health behaviors (Kouidrat et al. 2014). For 
example, in our study, smoking and alcohol consumption were more common among those 
with comorbid depression/psychotic experiences than depression alone. Furthermore, 
disordered eating has been related to psychotic experiences even after adjustment for non-
psychotic mental disorders (including depression) (Koyanagi et al. 2016b). Alternatively, 
psychotic symptoms have been associated with psychological distress regardless of 
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depression (Saha et al. 2011b), and this may be an important factor in the associations 
observed. Compared to other conditions, there are some reasons to believe that arthritis, 
angina, and diabetes may cause more distress. For example, while arthritis and chronic back 
pain are both painful conditions, arthritis was based on a lifetime diagnosis whereas chronic 
back pain was based on self-reported pain in the past 30 days with no information on severity. 
In settings where access to medical facilities is limited, diagnoses based solely on self-report 
such as arthritis may represent particularly severe cases as people may not seek medical help 
until the condition is critical. Furthermore, given that asthma is a condition that often remits, 
the fact that our definition for asthma was based on a lifetime diagnosis may mean that 
symptoms are were not currently present for some individuals. In contrast, arthritis, angina, 
and diabetes usually do not remit and may cause substantial disability and distress due to 
their chronic nature and symptoms, which may be aggravated especially in LMICs given that 
treatment options may be limited. The US study reported increased risks for medical 
hospitalizations in the past year in depression with psychotic “features” but not outpatients 
visits (Johnson et al. 1991). This may be mirroring our findings where only severe medical 
conditions might be associated with depression with psychotic “features” or psychotic 
experiences, possibly due to increased risk for psychological distress. Next, given that trauma 
has been linked to comorbid depression/psychotic experiences (Wigman et al. 2012), and that 
stress can lead to impaired hypothalamic-pituitary-adrenal (HPA) axis functioning, which in 
turn has been associated with increased risk for psychotic experiences (Thompson et al. 
2007) as well as diabetes, cardiovascular diseases (Rosmond & Bjorntorp, 2000), and arthritis 
(Muscatell & Eisenberger, 2012), this may be a shared underlying factor. Furthermore, in our 
previous study, co-existing depression/psychotic experiences was associated with 
interviewer-rated or observable mental health problems (Koyanagi et al. 2016a). Given that 
there may be a particularly high level of stigma attached to mental illnesses in LMICs 
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(Alonso et al. 2008), inequality in access to health care [resulting in under-detection of risk 
factors (e.g., hypercholesterolemia, hypertension) of more serious health conditions, and/or 
suboptimal treatment for the physical health conditions] for those with comorbid 
depression/psychotic experiences may also underlie our findings (De Hert et al. 2011a, 
2011b). Next, sleep problems, which have been associated with comorbid 
depression/psychotic experiences, may also be implicated (Koyanagi et al. 2014, 2016a). 
Finally, it is also possible that psychotic experiences in the context of depression are a 
reflection of more severe psychopathology. For example, previous studies have shown that 
higher numbers of mental disorder subtypes (i.e., depressive disorder, anxiety disorder, PTSD, 
substance use disorder) are associated with psychotic experiences in a dose-dependent 
fashion (DeVylder et al. 2014), while depression/psychotic experiences may also be a marker 
of more severe depression (Koyanagi et al. 2016a; Saha et al. 2012). As more severe 
psychopathology has also been associated with higher risks for chronic physical conditions 
(Scott et al. 2016), this may also explain the link between depression/psychotic experiences 
and chronic physical conditions observed in our study. 
 
Strengths and limitations 
To the best of our knowledge, our study is the first study to provide information on the 
prevalence and correlates of co-existing depression and psychotic experiences at the national 
level, while it is also the first study to assess the excess risk for chronic physical conditions 
associated with this condition. The strength of the study is the large sample size including 
predominantly nationally-representative data from diverse settings. The results should 
nevertheless be interpreted in the light of several potential limitations. First, since the data 
used in our study were based on self-report, reporting bias may have influenced responses 
(e.g., social desirability, recall). For example, social desirability may, at least partially, 
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account for the differences in the prevalence of some variables used in this study [e.g., 
psychotic experiences (DeVylder & Hilimire, 2015)]. Furthermore, medical conditions based 
solely on self-reported diagnosis (arthritis, asthma, diabetes) may be under-diagnosed where 
access to health care facilities is limited. Second, we did not have information on all types of 
psychotic symptoms or details on the exact nature of the psychotic experiences. In particular, 
it would have been desirable to have information on the latter as it is possible that some 
questions on psychotic experiences were misinterpreted by the respondent, or that they were 
reflections of “normal” experiences in some circumstances or cultures. Third, 
institutionalized individuals were not included in the survey, limiting generalizability. Next, 
the WHS countries were not randomly selected to represent all LMICs. Thus, the results of 
our studies may not be generalizable to all LMICs. Finally, causality cannot be inferred due 
to the cross-sectional nature of the data.  
 
Conclusion 
In conclusion, the prevalence of comorbid depression and psychotic experiences might not be 
negligible in many LMICs. Although depression was associated with higher odds for chronic 
back pain, edentulism, arthritis, angina, asthma, and diabetes, the co-existence of depression 
and psychotic experiences was associated with a higher odds beyond that of depression alone 
only for angina, arthritis, and diabetes. Given the increasing evidence that depression with 
psychotic experiences maybe a depression subtype associated with adverse health outcomes, 
while psychotic experiences and depression may mutually act to sustain and aggravate each 
other, our study suggests that when depression/psychotic experiences or a chronic condition 
(e.g., arthritis, angina, diabetes) is detected, screening for the other may be important. Future 
studies examining the reasons for the increased risk for comorbid depression/psychotic 
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experiences for some chronic conditions but not others may shed light on the significance and 
etiology of co-existing depression/psychotic experiences.  
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Table 1 Age- and sex-adjusted prevalence of depression with psychotic experiences by 
country 
Country N % (SE) Country N % (SE) 
Africa 
  
Asia 
  
Burkina Faso 4,948 4.12 (0.66) Bangladesh 5,942 2.87 (0.37) 
Chad 4,870 3.94 (0.67) China 3,994 0.29 (0.14) 
Comoros 1,836 2.62 (0.48) Georgia 2,950 0.50 (0.13) 
Congo 3,075 4.64 (1.11) India 10,687 4.54 (0.43) 
Ethiopia 5,089 2.59 (0.30) Kazakhstan 4,499 0.45 (0.13) 
Ghana 4,165 0.70 (0.16) Laos 4,988 0.45 (0.11) 
Ivory Coast 3,251 2.07 (0.42) Malaysia 6,145 0.60 (0.14) 
Kenya 4,640 3.28 (0.47) Myanmar 6,045 0.18 (0.07) 
Malawi 5,551 0.65 (0.15) Nepal 8,820 6.76 (0.37) 
Mali 4,886 2.70 (0.36) Pakistan 6,501 0.51 (0.10) 
Mauritania 3,902 1.01 (0.24) Philippines 10,083 0.86 (0.13) 
Mauritius 3,968 2.37 (0.32) Sri Lanka 6,805 0.10 (0.05) 
Namibia 4,379 1.63 (0.31) Vietnam 4,174 0.10 (0.07) 
Senegal 3,461 3.72 (0.63) Europe 
  
South Africa 2,629 1.99 (0.52) Bosnia Herzegovina 1,031 1.10 (0.42) 
Swaziland 3,117 3.77 (0.66) Croatia 993 0.61 (0.22) 
Tunisia 5,202 3.42 (0.44) Czech Republic 949 1.23 (0.54) 
Zambia 4,165 3.45 (0.56) Estonia 1,020 1.91 (0.44) 
Zimbabwe 4,290 1.20 (0.40) Hungary 1,419 0.69 (0.23) 
Americas 
  
Latvia 929 1.74 (0.49) 
Brazil 5,000 9.03 (0.55) Russia 4,427 0.62 (0.14) 
Dominican Republic 5,027 3.72 (0.47) Slovakia 2,535 2.33 (1.23) 
Ecuador 5,675 1.96 (0.37) Ukraine 2,860 1.35 (0.29) 
Mexico 38,746 1.77 (0.15) 
   
Paraguay 5,288 1.40 (0.21) 
   
Uruguay 2,996 0.92 (0.19)       
Abbreviation: SE standard error 
Dare are unweighted N and weighted %. 
The N is the total sample size including individuals with a psychosis diagnosis. 
Psychotic experiences referred to either one of: delusional mood, delusions of reference and persecution, 
delusions of control, or hallucinations. 
All age- and sex-adjusted estimates were calculated using the United Nations population pyramids for the year 
2010. 
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Table 2 Sample characteristics by different combinations of depression and psychotic experiences 
Characteristic 
(a) No 
depression or 
psychotic 
experiences 
(b) Depression 
without 
psychotic 
experiences 
(c) Depression 
with psychotic 
experiences 
P-valuea 
P-valueb 
(b) vs. (c) 
Age Mean (SD) 37.9 (15.9) 45.1 (15.9) 42.0 (15.1) <0.0001 0.0001 
Sex      
     Male 50.6 33.8 37.5 <0.0001 0.1760 
     Female 49.4 66.2 62.5 
  
Setting 
     
     Rural 58.0 61.1 53.1 0.0042 0.0008 
     Urban 42.0 38.9 46.9 
  
Marital status 
     
     Married/cohabiting 66.3 67.2 67.4 <0.0001 0.4825 
     Never married 24.3 12.7 14.2 
  
     Separated/divorced/widowed 9.4 20.0 18.5 
  
Education 
     
     No formal 25.4 41.5 31.2 <0.0001 0.0345 
     Primary 30.7 29.4 38.6 
  
     Secondary completed 33.9 22.8 23.4 
  
     Tertiary completed 10.0 6.2 6.9 
  
Wealth 
     
     Poorest 19.9 24.0 23.3 <0.0001 0.3628 
     Poorer 19.7 21.4 22.7 
  
     Middle 19.8 20.7 20.5 
  
     Richer 20.1 17.7 20.2 
  
     Richest 20.5 16.2 13.3 
  
Current smoker 
     
     No  74.0 72.4 68.0 0.0002 0.0172 
     Yes 26.0 27.6 32.0 
  
Alcohol consumption 
     
     Lifetime abstainer 68.2 71.6 57.7 <0.0001 <0.0001 
     Non-heavy 27.3 25.8 36.3 
  
     Infrequent heavy 3.5 2.1 4.5 
  
     Frequent heavy 1.0 0.5 1.5 
  
Anxiety 7.5 33.2 50.4 <0.0001 <0.0001 
Chronic conditions 
     
Chronic back pain 4.8 19.4 23.0 <0.0001 <0.0001 
Edentulism 5.1 10.4 10.9 <0.0001 0.0295 
Arthritis 11.4 24.5 26.6 <0.0001 0.7506 
Angina 12.0 32.8 36.8 <0.0001 0.0261 
Asthma 4.1 10.8 13.0 <0.0001 0.0733 
Diabetes 2.4 5.9 8.5 <0.0001 0.0070 
Number of chronic conditions 
     
     0 71.9 38.9 34.6 <0.0001 0.0144 
     1 19.5 32.1 32.4 
  
     2 6.5 18.9 19.1 
  
     ≥3 2.2 10.1 13.9     
Abbreviation: SD standard deviation 
Estimates are based on weighted sample. 
a Difference in sample characteristics by the three groups of different combinations of depression and psychotic experiences. One-
way ANOVA and Chi-squared tests were used for continuous and categorical variables respectively. 
b Pairwise comparison among those with depression with and without psychotic experiences. Student’s t-tests and Chi-squared 
tests were used for continuous and categorical variables respectively. 
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Abbreviation: OR odds ratio; CI confidence interval 
Models are adjusted for all variables in the respective column and country. 
* p<0.05, ** p<0.01, *** p<0.001 
 
 
 
 
 
 
Table 3 Associations between depression/psychotic experiences groups and physical health conditions estimated by multivariable logistic regression 
  Chronic back pain Edentulism Arthritis Angina Asthma Diabetes 
Characteristics OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI 
Depression/psychotic experiences groups 
            
     No depression/ No psychotic experiences 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
     Depression alone 2.29*** [1.93,2.72] 1.43* [1.09,1.89] 1.63*** [1.42,1.87] 2.46*** [2.19,2.77] 2.02*** [1.68,2.43] 1.57*** [1.21,2.03] 
     Depression and psychotic experiences 2.79*** [2.32,3.35] 1.39** [1.11,1.76] 2.12*** [1.80,2.49] 3.45*** [2.97,4.02] 1.89*** [1.53,2.34] 2.59*** [1.95,3.43] 
Age (years) 1.03*** [1.03,1.03] 1.07*** [1.07,1.08] 1.05*** [1.04,1.05] 1.03*** [1.03,1.03] 1.02*** [1.02,1.02] 1.06*** [1.05,1.07] 
Sex 
            
     Male 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
     Female 1.76*** [1.57,1.97] 1.34*** [1.21,1.48] 1.51*** [1.40,1.62] 1.54*** [1.44,1.64] 1.09 [0.99,1.21] 1.30*** [1.13,1.49] 
Setting 
            
     Rural 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
     Urban 0.97 [0.86,1.10] 1.17* [1.02,1.34] 0.98 [0.86,1.12] 0.97 [0.88,1.06] 1.00 [0.89,1.13] 1.48*** [1.24,1.76] 
Marital status 
            
     Married/cohabiting 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
     Never married 0.51*** [0.41,0.62] 1.20 [0.99,1.45] 0.75*** [0.65,0.86] 0.82*** [0.75,0.91] 1.17* [1.00,1.36] 0.61** [0.45,0.82] 
     Separated/divorced/widowed 0.86* [0.74,0.99] 1.03 [0.91,1.17] 0.89* [0.80,0.98] 0.95 [0.85,1.05] 1.01 [0.87,1.17] 0.78* [0.62,0.98] 
Education 
            
     No formal 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
     Primary 0.77*** [0.68,0.89] 1.02 [0.88,1.19] 1.10* [1.00,1.22] 1.04 [0.95,1.14] 0.93 [0.78,1.11] 2.01*** [1.55,2.59] 
     Secondary completed 0.66*** [0.55,0.79] 0.79* [0.66,0.95] 0.90 [0.79,1.02] 1.02 [0.90,1.16] 0.98 [0.81,1.18] 1.55** [1.16,2.07] 
     Tertiary completed 0.47*** [0.37,0.59] 0.52*** [0.41,0.65] 0.88 [0.74,1.05] 0.85 [0.71,1.00] 0.95 [0.70,1.28] 1.78*** [1.27,2.51] 
Wealth 
            
     Poorest 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
     Poorer 0.99 [0.85,1.15] 1.09 [0.95,1.26] 1.08 [0.97,1.20] 0.97 [0.88,1.07] 1.03 [0.89,1.20] 1.24* [1.00,1.54] 
     Middle 1.05 [0.90,1.22] 0.97 [0.82,1.14] 0.97 [0.87,1.08] 0.84*** [0.76,0.92] 1.00 [0.87,1.16] 1.30* [1.04,1.64] 
     Richer 0.99 [0.85,1.16] 1.03 [0.88,1.22] 0.97 [0.85,1.10] 0.76*** [0.69,0.85] 1.14 [0.98,1.33] 1.57*** [1.25,1.97] 
     Richest 1.12 [0.93,1.34] 0.98 [0.82,1.17] 0.91 [0.78,1.05] 0.73*** [0.64,0.82] 1.15 [0.98,1.35] 2.21*** [1.72,2.84] 
Anxiety 2.02*** [1.77,2.31] 0.94 [0.81,1.10] 1.33*** [1.19,1.49] 1.70*** [1.53,1.89] 1.46*** [1.25,1.72] 1.51** [1.18,1.94] 
